Unique platform

Physics-based approach to estimate ligand protein binding affinities.

Extensively tested

Benchmarked on all major industry standard datasets.

Fast and cost-efficient

Our MD engine, Q, works efficiently on modern hardware architecture.

Technology

Our proprietary physics-based software platform is designed to increase performance and throughput in early stage drug discovery.

Application areas

Our platform has been used in lead optimization projects on various target classes (e.g. GPCRs, kinases, lactamases), to predict thermal stability of proteins and the effect of point mutations on ligand binding.

Let’s work together on your
drug discovery project

[email protected]